Login / Signup

Real-world prevalence of integrase inhibitor resistance and virological failure since adoption as guideline-preferred therapy.

Jenna JanuszkaEmily DrwiegaRodrigo BurgosRenata SmithMelissa Badowski
Published in: Drugs in context (2024)
Amongst participants on INSTI-containing regimens, INSTI-R rates were estimated to be lower than the estimated national prevalence. Detectable pre-switch viral loads were more associated with VF than undetectable viral loads.
Keyphrases
  • risk factors
  • sars cov
  • hiv infected
  • quality improvement
  • antiretroviral therapy
  • stem cells
  • hiv infected patients
  • bone marrow